APO Research
Talk to an analyst

APO RESEARCH · REPORT

Functional Genomics

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Functional Genomics Market Analysis and Forecast 2026-2032

5 July 2026177 pages

Choose your research edition.

Industry ResearchFunctional Genomics Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Functional Genomics Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Functional Genomics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Functional Genomics Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Functional Genomics Market Analysis and Forecast 2026-2032177 pages · $4,950 USD

Market perspective

The global Functional Genomics market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Functional Genomics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Functional Genomics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Functional Genomics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Functional Genomics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Functional Genomics include Agilent Technologies, Inc., Becton, Dickinson and Company (BD), Bio-Rad Laboratories, Inc., (Integrated DNA Technologies, Inc.), Exact Sciences Corporation, Hoffmann-La Roche Ltd, Illumina, Inc., Merck KGaA and MRM Proteomics, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Functional Genomics, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Functional Genomics, also provides the revenue of main regions and countries. Of the upcoming market potential for Functional Genomics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Functional Genomics revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Functional Genomics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Functional Genomics revenue, projected growth trends, production technology, application and end-user industry.

Functional Genomics Segment by Company

Agilent Technologies, Inc.

Becton, Dickinson and Company (BD)

Bio-Rad Laboratories, Inc.

(Integrated DNA Technologies, Inc.)

Exact Sciences Corporation

Hoffmann-La Roche Ltd

Illumina, Inc.

Merck KGaA

MRM Proteomics

Pacific Biosciences of California, Inc.

Promega Corporation

QIAGEN

Thermo Fisher Scientific Inc.

Functional Genomics Segment by Type

Kits & Assays

Instruments

Assays

Functional Genomics Segment by Application

Transcriptomics

Epigenomics

Proteomics

Metabolomics

Functional Genomics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Functional Genomics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Functional Genomics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Functional Genomics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Functional Genomics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Functional Genomics company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Functional Genomics revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Functional Genomics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Kits & Assays Major Player Table 3. Instruments Major Player Table 4. Assays Major Player Table 5. Global Functional Genomics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Transcriptomics Major Player Table 7. Epigenomics Major Player Table 8. Proteomics Major Player Table 9. Metabolomics Major Player Table 10. Functional Genomics Industry Trends Table 11. Functional Genomics Industry Drivers Table 12. Functional Genomics Industry Opportunities and Challenges Table 13. Functional Genomics Industry Restraints Table 14. Global Functional Genomics Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Functional Genomics Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Functional Genomics Market Share by Region (2021-2026) Table 17. Global Functional Genomics Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Functional Genomics Market Share by Region (2027-2032) Table 19. Global Functional Genomics Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Functional Genomics Revenue Market Share by Players (2021-2026) Table 21. Global Functional Genomics Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Functional Genomics Key Players Headquarters & Area Served Table 23. Global Functional Genomics Players, Product Type & Application Table 24. Global Functional Genomics Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Functional Genomics by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Functional Genomics Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Functional Genomics Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Functional Genomics Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Functional Genomics Revenue Market Share by Type (2021-2026) Table 31. Global Functional Genomics Revenue Market Share by Type (2027-2032) Table 32. Global Functional Genomics Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Functional Genomics Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Functional Genomics Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Functional Genomics Revenue Market Share by Application (2021-2026) Table 36. Global Functional Genomics Revenue Market Share by Application (2027-2032) Table 37. Agilent Technologies, Inc. Company Information Table 38. Agilent Technologies, Inc. Business Overview Table 39. Agilent Technologies, Inc. Functional Genomics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Agilent Technologies, Inc. Functional Genomics Product Portfolio Table 41. Agilent Technologies, Inc. Recent Development Table 42. Becton, Dickinson and Company (BD) Company Information Table 43. Becton, Dickinson and Company (BD) Business Overview Table 44. Becton, Dickinson and Company (BD) Functional Genomics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Becton, Dickinson and Company (BD) Functional Genomics Product Portfolio Table 46. Becton, Dickinson and Company (BD) Recent Development Table 47. Bio-Rad Laboratories, Inc. Company Information Table 48. Bio-Rad Laboratories, Inc. Business Overview Table 49. Bio-Rad Laboratories, Inc. Functional Genomics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Bio-Rad Laboratories, Inc. Functional Genomics Product Portfolio Table 51. Bio-Rad Laboratories, Inc. Recent Development Table 52. (Integrated DNA Technologies, Inc.) Company Information Table 53. (Integrated DNA Technologies, Inc.) Business Overview Table 54. (Integrated DNA Technologies, Inc.) Functional Genomics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. (Integrated DNA Technologies, Inc.) Functional Genomics Product Portfolio Table 56. (Integrated DNA Technologies, Inc.) Recent Development Table 57. Exact Sciences Corporation Company Information Table 58. Exact Sciences Corporation Business Overview Table 59. Exact Sciences Corporation Functional Genomics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Exact Sciences Corporation Functional Genomics Product Portfolio Table 61. Exact Sciences Corporation Recent Development Table 62. Hoffmann-La Roche Ltd Company Information Table 63. Hoffmann-La Roche Ltd Business Overview Table 64. Hoffmann-La Roche Ltd Functional Genomics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Hoffmann-La Roche Ltd Functional Genomics Product Portfolio Table 66. Hoffmann-La Roche Ltd Recent Development Table 67. Illumina, Inc. Company Information Table 68. Illumina, Inc. Business Overview Table 69. Illumina, Inc. Functional Genomics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Illumina, Inc. Functional Genomics Product Portfolio Table 71. Illumina, Inc. Recent Development Table 72. Merck KGaA Company Information Table 73. Merck KGaA Business Overview Table 74. Merck KGaA Functional Genomics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Merck KGaA Functional Genomics Product Portfolio Table 76. Merck KGaA Recent Development Table 77. MRM Proteomics Company Information Table 78. MRM Proteomics Business Overview Table 79. MRM Proteomics Functional Genomics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. MRM Proteomics Functional Genomics Product Portfolio Table 81. MRM Proteomics Recent Development Table 82. Pacific Biosciences of California, Inc. Company Information Table 83. Pacific Biosciences of California, Inc. Business Overview Table 84. Pacific Biosciences of California, Inc. Functional Genomics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Pacific Biosciences of California, Inc. Functional Genomics Product Portfolio Table 86. Pacific Biosciences of California, Inc. Recent Development Table 87. Promega Corporation Company Information Table 88. Promega Corporation Business Overview Table 89. Promega Corporation Functional Genomics Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Promega Corporation Functional Genomics Product Portfolio Table 91. Promega Corporation Recent Development Table 92. QIAGEN Company Information Table 93. QIAGEN Business Overview Table 94. QIAGEN Functional Genomics Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. QIAGEN Functional Genomics Product Portfolio Table 96. QIAGEN Recent Development Table 97. Thermo Fisher Scientific Inc. Company Information Table 98. Thermo Fisher Scientific Inc. Business Overview Table 99. Thermo Fisher Scientific Inc. Functional Genomics Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Thermo Fisher Scientific Inc. Functional Genomics Product Portfolio Table 101. Thermo Fisher Scientific Inc. Recent Development Table 102. North America Functional Genomics Revenue by Type (2021-2026) & (US$ Million) Table 103. North America Functional Genomics Revenue by Type (2027-2032) & (US$ Million) Table 104. North America Functional Genomics Revenue by Application (2021-2026) & (US$ Million) Table 105. North America Functional Genomics Revenue by Application (2027-2032) & (US$ Million) Table 106. North America Functional Genomics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. North America Functional Genomics Revenue by Country (2021-2026) & (US$ Million) Table 108. North America Functional Genomics Revenue by Country (US$ Million) & (2027-2032) Table 109. Europe Functional Genomics Revenue by Type (2021-2026) & (US$ Million) Table 110. Europe Functional Genomics Revenue by Type (2027-2032) & (US$ Million) Table 111. Europe Functional Genomics Revenue by Application (2021-2026) & (US$ Million) Table 112. Europe Functional Genomics Revenue by Application (2027-2032) & (US$ Million) Table 113. Europe Functional Genomics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. Europe Functional Genomics Revenue by Country (2021-2026) & (US$ Million) Table 115. Europe Functional Genomics Revenue by Country (US$ Million) & (2027-2032) Table 116. China Functional Genomics Revenue by Type (2021-2026) & (US$ Million) Table 117. China Functional Genomics Revenue by Type (2027-2032) & (US$ Million) Table 118. China Functional Genomics Revenue by Application (2021-2026) & (US$ Million) Table 119. China Functional Genomics Revenue by Application (2027-2032) & (US$ Million) Table 120. Asia Functional Genomics Revenue by Type (2021-2026) & (US$ Million) Table 121. Asia Functional Genomics Revenue by Type (2027-2032) & (US$ Million) Table 122. Asia Functional Genomics Revenue by Application (2021-2026) & (US$ Million) Table 123. Asia Functional Genomics Revenue by Application (2027-2032) & (US$ Million) Table 124. Asia Functional Genomics Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 125. Asia Functional Genomics Revenue by Region (US$ Million) & (2021-2026) Table 126. Asia Functional Genomics Revenue by Region (US$ Million) & (2027-2032) Table 127. SAMEA Functional Genomics Revenue by Type (2021-2026) & (US$ Million) Table 128. SAMEA Functional Genomics Revenue by Type (2027-2032) & (US$ Million) Table 129. SAMEA Functional Genomics Revenue by Application (2021-2026) & (US$ Million) Table 130. SAMEA Functional Genomics Revenue by Application (2027-2032) & (US$ Million) Table 131. SAMEA Functional Genomics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. SAMEA Functional Genomics Revenue by Country (2021-2026) & (US$ Million) Table 133. SAMEA Functional Genomics Revenue by Country (US$ Million) & (2027-2032) Table 134. Research Programs/Design for This Report Table 135. Authors List of This Report Table 136. Secondary Sources Table 137. Primary Sources List of Figures Figure 1. Functional Genomics Image Figure 2. Global Functional Genomics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Functional Genomics Market Size Share 2021 VS 2025 VS 2032 Figure 4. Kits & Assays Image Figure 5. Instruments Image Figure 6. Assays Image Figure 7. Global Functional Genomics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Functional Genomics Market Size Share 2021 VS 2025 VS 2032 Figure 9. Transcriptomics Image Figure 10. Epigenomics Image Figure 11. Proteomics Image Figure 12. Metabolomics Image Figure 13. Global Functional Genomics Market Size (US$ Million) & (2021-2032) Figure 14. Global Functional Genomics Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Functional Genomics Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Functional Genomics Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Functional Genomics Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Functional Genomics Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Functional Genomics Revenue Market Share by Type (2021-2032) Figure 21. Global Functional Genomics Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Functional Genomics Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Functional Genomics Revenue Market Share by Application (2021-2032) Figure 24. North America Functional Genomics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Functional Genomics Revenue Share by Type (2021-2032) Figure 26. North America Functional Genomics Revenue Share by Application (2021-2032) Figure 27. North America Functional Genomics Revenue Share by Country (2021-2032) Figure 28. United States Functional Genomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Functional Genomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Functional Genomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Functional Genomics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Functional Genomics Revenue Share by Type (2021-2032) Figure 33. Europe Functional Genomics Revenue Share by Application (2021-2032) Figure 34. Europe Functional Genomics Revenue Share by Country (2021-2032) Figure 35. Germany Functional Genomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Functional Genomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Functional Genomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Functional Genomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Functional Genomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Functional Genomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Functional Genomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Functional Genomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Functional Genomics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Functional Genomics Revenue Share by Type (2021-2032) Figure 45. China Functional Genomics Revenue Share by Application (2021-2032) Figure 46. Asia Functional Genomics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Functional Genomics Revenue Share by Type (2021-2032) Figure 48. Asia Functional Genomics Revenue Share by Application (2021-2032) Figure 49. Asia Functional Genomics Revenue Share by Region (2021-2032) Figure 50. Japan Functional Genomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Functional Genomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Functional Genomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Functional Genomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Functional Genomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Functional Genomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Functional Genomics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Functional Genomics Revenue Share by Type (2021-2032) Figure 58. SAMEA Functional Genomics Revenue Share by Application (2021-2032) Figure 59. SAMEA Functional Genomics Revenue Share by Country (2021-2032) Figure 60. Brazil Functional Genomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Functional Genomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Functional Genomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Functional Genomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Functional Genomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Functional Genomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Functional Genomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Functional Genomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Functional Genomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Functional Genomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Functional Genomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Kits & Assays
  • Instruments
  • Assays
Applications
  • Transcriptomics
  • Epigenomics
  • Proteomics
  • Metabolomics
Companies covered
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company (BD)
  • Bio-Rad Laboratories, Inc.
  • (Integrated DNA Technologies, Inc.)
  • Exact Sciences Corporation
  • Hoffmann-La Roche Ltd
  • Illumina, Inc.
  • Merck KGaA
  • MRM Proteomics
  • Pacific Biosciences of California, Inc.
  • Promega Corporation
  • QIAGEN
  • Thermo Fisher Scientific Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Functional Genomics Market by Type
  3. 1.2.1 Global Functional Genomics Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Kits & Assays
  5. 1.2.3 Instruments
  6. 1.2.4 Assays
  7. 1.3 Functional Genomics Market by Application
  8. 1.3.1 Global Functional Genomics Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Transcriptomics
  10. 1.3.3 Epigenomics
  11. 1.3.4 Proteomics
  12. 1.3.5 Metabolomics
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Functional Genomics Market Dynamics
  1. 2.1 Functional Genomics Industry Trends
  2. 2.2 Functional Genomics Industry Drivers
  3. 2.3 Functional Genomics Industry Opportunities and Challenges
  4. 2.4 Functional Genomics Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Functional Genomics Market Perspective (2021-2032)
  2. 3.2 Global Functional Genomics Growth Trends by Region
  3. 3.2.1 Global Functional Genomics Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Functional Genomics Market Size by Region (2021-2026)
  5. 3.2.3 Global Functional Genomics Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Functional Genomics Revenue by Players
  2. 4.1.1 Global Functional Genomics Revenue by Players (2021-2026)
  3. 4.1.2 Global Functional Genomics Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Functional Genomics Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Functional Genomics Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Functional Genomics Key Players Headquarters & Area Served
  7. 4.4 Global Functional Genomics Players, Product Type & Application
  8. 4.5 Global Functional Genomics Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Functional Genomics Market CR5 and HHI
  11. 4.6.3 2025 Functional Genomics Tier 1, Tier 2, and Tier 3
5 Functional Genomics Market Size by Type
  1. 5.1 Global Functional Genomics Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Functional Genomics Revenue by Type (2021-2032)
  3. 5.3 Global Functional Genomics Revenue Market Share by Type (2021-2032)
6 Functional Genomics Market Size by Application
  1. 6.1 Global Functional Genomics Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Functional Genomics Revenue by Application (2021-2032)
  3. 6.3 Global Functional Genomics Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Agilent Technologies, Inc.
  2. 7.1.1 Agilent Technologies, Inc. Company Information
  3. 7.1.2 Agilent Technologies, Inc. Business Overview
  4. 7.1.3 Agilent Technologies, Inc. Functional Genomics Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Agilent Technologies, Inc. Functional Genomics Product Portfolio
  6. 7.1.5 Agilent Technologies, Inc. Recent Developments
  7. 7.2 Becton, Dickinson and Company (BD)
  8. 7.2.1 Becton, Dickinson and Company (BD) Company Information
  9. 7.2.2 Becton, Dickinson and Company (BD) Business Overview
  10. 7.2.3 Becton, Dickinson and Company (BD) Functional Genomics Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Becton, Dickinson and Company (BD) Functional Genomics Product Portfolio
  12. 7.2.5 Becton, Dickinson and Company (BD) Recent Developments
  13. 7.3 Bio-Rad Laboratories, Inc.
  14. 7.3.1 Bio-Rad Laboratories, Inc. Company Information
  15. 7.3.2 Bio-Rad Laboratories, Inc. Business Overview
  16. 7.3.3 Bio-Rad Laboratories, Inc. Functional Genomics Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Bio-Rad Laboratories, Inc. Functional Genomics Product Portfolio
  18. 7.3.5 Bio-Rad Laboratories, Inc. Recent Developments
  19. 7.4 (Integrated DNA Technologies, Inc.)
  20. 7.4.1 (Integrated DNA Technologies, Inc.) Company Information
  21. 7.4.2 (Integrated DNA Technologies, Inc.) Business Overview
  22. 7.4.3 (Integrated DNA Technologies, Inc.) Functional Genomics Revenue and Gross Margin (2021-2026)
  23. 7.4.4 (Integrated DNA Technologies, Inc.) Functional Genomics Product Portfolio
  24. 7.4.5 (Integrated DNA Technologies, Inc.) Recent Developments
  25. 7.5 Exact Sciences Corporation
  26. 7.5.1 Exact Sciences Corporation Company Information
  27. 7.5.2 Exact Sciences Corporation Business Overview
  28. 7.5.3 Exact Sciences Corporation Functional Genomics Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Exact Sciences Corporation Functional Genomics Product Portfolio
  30. 7.5.5 Exact Sciences Corporation Recent Developments
  31. 7.6 Hoffmann-La Roche Ltd
  32. 7.6.1 Hoffmann-La Roche Ltd Company Information
  33. 7.6.2 Hoffmann-La Roche Ltd Business Overview
  34. 7.6.3 Hoffmann-La Roche Ltd Functional Genomics Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Hoffmann-La Roche Ltd Functional Genomics Product Portfolio
  36. 7.6.5 Hoffmann-La Roche Ltd Recent Developments
  37. 7.7 Illumina, Inc.
  38. 7.7.1 Illumina, Inc. Company Information
  39. 7.7.2 Illumina, Inc. Business Overview
  40. 7.7.3 Illumina, Inc. Functional Genomics Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Illumina, Inc. Functional Genomics Product Portfolio
  42. 7.7.5 Illumina, Inc. Recent Developments
  43. 7.8 Merck KGaA
  44. 7.8.1 Merck KGaA Company Information
  45. 7.8.2 Merck KGaA Business Overview
  46. 7.8.3 Merck KGaA Functional Genomics Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Merck KGaA Functional Genomics Product Portfolio
  48. 7.8.5 Merck KGaA Recent Developments
  49. 7.9 MRM Proteomics
  50. 7.9.1 MRM Proteomics Company Information
  51. 7.9.2 MRM Proteomics Business Overview
  52. 7.9.3 MRM Proteomics Functional Genomics Revenue and Gross Margin (2021-2026)
  53. 7.9.4 MRM Proteomics Functional Genomics Product Portfolio
  54. 7.9.5 MRM Proteomics Recent Developments
  55. 7.10 Pacific Biosciences of California, Inc.
  56. 7.10.1 Pacific Biosciences of California, Inc. Company Information
  57. 7.10.2 Pacific Biosciences of California, Inc. Business Overview
  58. 7.10.3 Pacific Biosciences of California, Inc. Functional Genomics Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Pacific Biosciences of California, Inc. Functional Genomics Product Portfolio
  60. 7.10.5 Pacific Biosciences of California, Inc. Recent Developments
  61. 7.11 Promega Corporation
  62. 7.11.1 Promega Corporation Company Information
  63. 7.11.2 Promega Corporation Business Overview
  64. 7.11.3 Promega Corporation Functional Genomics Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Promega Corporation Functional Genomics Product Portfolio
  66. 7.11.5 Promega Corporation Recent Developments
  67. 7.12 QIAGEN
  68. 7.12.1 QIAGEN Company Information
  69. 7.12.2 QIAGEN Business Overview
  70. 7.12.3 QIAGEN Functional Genomics Revenue and Gross Margin (2021-2026)
  71. 7.12.4 QIAGEN Functional Genomics Product Portfolio
  72. 7.12.5 QIAGEN Recent Developments
  73. 7.13 Thermo Fisher Scientific Inc.
  74. 7.13.1 Thermo Fisher Scientific Inc. Company Information
  75. 7.13.2 Thermo Fisher Scientific Inc. Business Overview
  76. 7.13.3 Thermo Fisher Scientific Inc. Functional Genomics Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Thermo Fisher Scientific Inc. Functional Genomics Product Portfolio
  78. 7.13.5 Thermo Fisher Scientific Inc. Recent Developments
8 North America
  1. 8.1 North America Functional Genomics Revenue (2021-2032)
  2. 8.2 North America Functional Genomics Revenue by Type (2021-2032)
  3. 8.2.1 North America Functional Genomics Revenue by Type (2021-2026)
  4. 8.2.2 North America Functional Genomics Revenue by Type (2027-2032)
  5. 8.3 North America Functional Genomics Revenue Share by Type (2021-2032)
  6. 8.4 North America Functional Genomics Revenue by Application (2021-2032)
  7. 8.4.1 North America Functional Genomics Revenue by Application (2021-2026)
  8. 8.4.2 North America Functional Genomics Revenue by Application (2027-2032)
  9. 8.5 North America Functional Genomics Revenue Share by Application (2021-2032)
  10. 8.6 North America Functional Genomics Revenue by Country
  11. 8.6.1 North America Functional Genomics Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Functional Genomics Revenue by Country (2021-2026)
  13. 8.6.3 North America Functional Genomics Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Functional Genomics Revenue (2021-2032)
  2. 9.2 Europe Functional Genomics Revenue by Type (2021-2032)
  3. 9.2.1 Europe Functional Genomics Revenue by Type (2021-2026)
  4. 9.2.2 Europe Functional Genomics Revenue by Type (2027-2032)
  5. 9.3 Europe Functional Genomics Revenue Share by Type (2021-2032)
  6. 9.4 Europe Functional Genomics Revenue by Application (2021-2032)
  7. 9.4.1 Europe Functional Genomics Revenue by Application (2021-2026)
  8. 9.4.2 Europe Functional Genomics Revenue by Application (2027-2032)
  9. 9.5 Europe Functional Genomics Revenue Share by Application (2021-2032)
  10. 9.6 Europe Functional Genomics Revenue by Country
  11. 9.6.1 Europe Functional Genomics Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Functional Genomics Revenue by Country (2021-2026)
  13. 9.6.3 Europe Functional Genomics Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Functional Genomics Revenue (2021-2032)
  2. 10.2 China Functional Genomics Revenue by Type (2021-2032)
  3. 10.2.1 China Functional Genomics Revenue by Type (2021-2026)
  4. 10.2.2 China Functional Genomics Revenue by Type (2027-2032)
  5. 10.3 China Functional Genomics Revenue Share by Type (2021-2032)
  6. 10.4 China Functional Genomics Revenue by Application (2021-2032)
  7. 10.4.1 China Functional Genomics Revenue by Application (2021-2026)
  8. 10.4.2 China Functional Genomics Revenue by Application (2027-2032)
  9. 10.5 China Functional Genomics Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Functional Genomics Revenue (2021-2032)
  2. 11.2 Asia Functional Genomics Revenue by Type (2021-2032)
  3. 11.2.1 Asia Functional Genomics Revenue by Type (2021-2026)
  4. 11.2.2 Asia Functional Genomics Revenue by Type (2027-2032)
  5. 11.3 Asia Functional Genomics Revenue Share by Type (2021-2032)
  6. 11.4 Asia Functional Genomics Revenue by Application (2021-2032)
  7. 11.4.1 Asia Functional Genomics Revenue by Application (2021-2026)
  8. 11.4.2 Asia Functional Genomics Revenue by Application (2027-2032)
  9. 11.5 Asia Functional Genomics Revenue Share by Application (2021-2032)
  10. 11.6 Asia Functional Genomics Revenue by Country
  11. 11.6.1 Asia Functional Genomics Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Functional Genomics Revenue by Country (2021-2026)
  13. 11.6.3 Asia Functional Genomics Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Functional Genomics Revenue (2021-2032)
  2. 12.2 SAMEA Functional Genomics Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Functional Genomics Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Functional Genomics Revenue by Type (2027-2032)
  5. 12.3 SAMEA Functional Genomics Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Functional Genomics Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Functional Genomics Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Functional Genomics Revenue by Application (2027-2032)
  9. 12.5 SAMEA Functional Genomics Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Functional Genomics Revenue by Country
  11. 12.6.1 SAMEA Functional Genomics Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Functional Genomics Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Functional Genomics Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst